Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Running

SPARTHACUS Innovative multifunctional and smart coatings to prevent medical device related infections

Coordinator
Spartha Medical, France
Runs
1 August 2022 to 31 July 2025
Status
Running
EU funding
€2.4m
Total cost
€3.4m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190184905

What the project is doing

In the project's own words, from its summary on CORDIS.

Infections represent one of the major risks of surgery implants and the main cause of implant rejection, affecting over 5% of patients who undergo an implant surgery (around 2M patients in the EU). At SPARTHA Medical, created in 2019 as a spin-off of INSERM Biomaterials Unit (Strasbourg), we developed a multifunctional coating with antimicrobial and anti-inflammatory properties to prevent infections in implants and surgical care.

In addition to this medical coating to be used directly in hospitals, we developed a second product a biocompatible, eco-friendly spray with antibacterial & antiviral properties for general and daily use. We also offer a customized coating development service for medical device manufacturers which leads to recurring licensing. Our coating platform is so versatile the applications are endless. We are also integrating the development service to electronics and cosmetics companies.

We have signed 7 contract agreements so far, and 2 more in advanced negotiations.

Topics

Who is involved

OrganisationCityCountryRole
Spartha MedicalStrasbourgFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI